BioSpace News Archive

Biotech Bay

Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris

Seven patients successfully treated using next generation image-guided atherectomy device for treatment of peripheral artery disease.

January 3, 2018
·
5 min read
Drug Development

Enteris BioPharma Announces Positive Results From Phase IIa Clinical Trial of Ovarest (oral leuprolide tablet) for Endometriosis

Data from the study indicated that Ovarest enabled significant suppression of estradiol, demonstrating a measurable pharmacodynamic effect that is tightly correlated with efficacy in endometriosis.

January 3, 2018
·
5 min read
Pharm Country

VenatoRx Pharmaceuticals Receives FDA’s QIDP and Fast Track Designations for Development of Its Lead Antibiotic Program

The designations were granted for both complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

January 3, 2018
·
3 min read
Drug Development

Rasna Therapeutics, Inc., Announces Follow Up Phase II Clinical Data Confirming Efficacy of Actinomycin D in Patients with NPM1-Mutated Acute Myeloid Leukemia

Rasna Therapeutics today announced follow up Phase II clinical data showing that 4 out of 9 (44%) evaluable AML patients carrying the NPM1 gene mutation treated with actinomycin D (“Act D”), achieved complete remission (CR).

January 3, 2018
·
5 min read
Business

Anthera Pharmaceuticals Announces Appointment of Patrick Murphy as Senior Vice President, Manufacturing

In his new role, Patrick will oversee the manufacturing commercial scale-up of Sollpura.

January 3, 2018
·
2 min read
Generex Provides Access Information for Investor Conference Call Scheduled for January 4, 2018

Generex today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team, tomorrow, Thursday, January 4, 2018, at 10:30 a.m. Eastern time.

January 3, 2018
·
1 min read
Business

CIRCULOGENE Announces International Licensing of Proprietary Molecular Diagnostics Testing Technology to Turkey-Based Laboratory

Under terms of the agreement, CIRCULOGENE’s low-volume, high-yield, extraction-free and loss-free sample preparation coupled with next-generation sequencing technology is being licensed to CIRCULOGENE Saglik of Istanbul, Turkey.

January 3, 2018
·
3 min read
BioCapital

Inovalon Announces Charitable Giving for 2017

Inovalon demonstrates strong ongoing commitment to local and national organizations through several charitable giving programs.

January 3, 2018
·
6 min read
Genetown

Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference

Oxford Immunotec Global PLC today announced that Dr. Peter Wrighton-Smith, CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018, at 11:00 a.m. PST.

January 3, 2018
·
3 min read
Business

Myriad Genetics Announces Expanded Research Collaboration With AstraZeneca

Financial terms of the deal were not disclosed.

January 3, 2018
·
8 min read